Who are Oncopatch's investors?

Oncopatch's investors include FirstMile Ventures, MINES VENTURE.

How much funding has Oncopatch raised?

Oncopatch has disclosed $418.8K raised across 1 round.

Where is Oncopatch headquartered?

Oncopatch is headquartered in Boulder, US.

Oncopatch

Boulder, US · Founded 2023 · Delaware corporation · 2 known investors

Find your way into Oncopatch

309 people in our graph share verified history with the Oncopatch team — schools, employers, funds. One of them is your warm intro.

Doug Nealunlockedknows Jeramy Zimmerman · together at University of Michigan (overlapped)

×6knows the team · via UC Santa Barbara

knows the team · via University of Michigan

×2knows the team · via University of Adelaide

×2knows the team · via Colorado School of Mines

OncoPatch develops a non-invasive medical patch that delivers low-energy beta therapy to treat non-melanoma skin cancers, including basal and squamous cell carcinomas. The single-application treatment is administered in a physician's office and targets cancer cells while sparing healthy tissue.

Biotech Medical Devices

Founders & leadership

Oncopatch was founded in 2023 by David Westerly, Quentin Diot, Frederic Sarazin, and Jeramy Zimmerman.

David Westerly inCo-founder & CEODavid Westerly is a medical physicist and Associate Professor of Radiation Oncology at CU Anschutz, holding a Master's in Nuclear Engineering and a PhD in Medical Physics from the University of Wisconsin–Madison. As co-founder and CEO of OncoPatch, he leads the development of a non-invasive patch delivering beta therapy for non-melanoma skin cancers.

Quentin DiotCo-founder

Frederic Sarazin inCo-founderFrederic Sarazin is a physicist with research expertise in low-energy nuclear physics and medical physics applications, who has held leadership roles as head of a physics department and director of Quantum@Mines. He is co-founder of OncoPatch, which develops a non-invasive medical patch for treating non-melanoma skin cancers.

Jeramy Zimmerman inCo-founderJeramy Zimmerman is co-founder of OncoPatch and leads product development and manufacturing for the company's non-invasive radiotherapy patch for skin cancer treatment. He has background in materials science with expertise in thin-film deposition techniques, vacuum systems, and electronic materials including semiconductors and organic optoelectronic devices.

Board

Bill Miller in 𝕏Board directorFounder / Managing Partner at FirstMile Ventures

Investors · 2

FirstMile VenturesDenver · $300K – $800K

MINES VENTUREGolden

Reported raises · per SEC filings

Form D private placements

$418.8K disclosed across 1 round · 2025

▶$418.8KraisedDec 2025 · 5 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Quentin DiotExecutive Officer, Promoter
Frederic SarazinExecutive Officer, Director, Promoter
David Clark WesterlyExecutive Officer, Director, Promoter
Bill MillerDirector
Jeramy ZimmermanExecutive Officer, Promoter

Offering amount: $2M
Amount sold: $418.8K
First sale: Oct 2025
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Oncosenx3 shared keywordsOncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

Companies competing with Oncopatch for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Oncopatch do?: OncoPatch develops a non-invasive medical patch that delivers low-energy beta therapy to treat non-melanoma skin cancers, including basal and squamous cell carcinomas. The single-application treatment is administered in a physician's office and targets cancer cells while sparing healthy tissue.
Who founded Oncopatch?: Oncopatch was founded by David Westerly, Quentin Diot, Frederic Sarazin, Jeramy Zimmerman in 2023.
Who are Oncopatch's investors?: Oncopatch's investors include FirstMile Ventures, MINES VENTURE.
How much funding has Oncopatch raised?: Oncopatch has disclosed $418.8K raised across 1 round.
Where is Oncopatch headquartered?: Oncopatch is headquartered in Boulder, US.